Your browser doesn't support javascript.
loading
Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type-B receptor 4.
Ma, Weina; Zhu, Man; Wang, Bo; Gong, Zhengyan; Du, Xia; Yang, Tianfeng; Shi, Xianpeng; Dai, Bingling; Zhan, Yingzhuan; Zhang, Dongdong; Ji, Yanhong; Wang, Yang; Li, Song; Zhang, Yanmin.
Afiliação
  • Ma W; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China.
  • Zhu M; State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi'an, China.
  • Wang B; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China.
  • Gong Z; State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi'an, China.
  • Du X; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China.
  • Yang T; State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi'an, China.
  • Shi X; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China.
  • Dai B; State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi'an, China.
  • Zhan Y; Institute of Traditional Chinese Medicine, Shaanxi Academy of Traditional Chinese Medicine, Xi'an, China.
  • Zhang D; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China.
  • Ji Y; State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi'an, China.
  • Wang Y; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China.
  • Li S; State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi'an, China.
  • Zhang Y; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China.
Mol Oncol ; 16(14): 2747-2765, 2022 07.
Article em En | MEDLINE | ID: mdl-35689424

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
...